FDA Removes BPC 157, TB 500 and 10 More Peptides from Category 2 (April 2026) HIMS: Regulatory Arbitrage and the Future of Personalized Medicine Understanding the Legal Risks of BPC 157 and Other Unapproved Peptides Holt Law Not all peptides are restricted. Here's the breakdown you actually need. The FDA's Category 2 classification affects specific compounded peptides BPC 157, TB 500, CJC 1295 Ipamorelin, AOD 9604, Epithalon, Selank, Semax. Others like Sermorelin FDA Peptide Ban Lifted: Legit Compounding Pharmacies Now Regulate Julian Becerra posted on the topic LinkedIn